Epigenetic control of lipid metabolism: Implications for lifespan and healthspan

TY - JOUR

T1 - Epigenetic control of lipid metabolism

T2 - Implications for lifespan and healthspan

AU - Schiattarella, Gabriele G.

AU - Hill, Joseph A

N1 - Funding Information: Dr. Gabriele G. Schiattarella is a researcher at the University of Texas Southwestern Medical Center in Dallas, TX, USA. He received his MD in 2009 from the University Federico II of Naples (Italy). After completing a fellowship in Cardiology at the same university (2015) and matriculating in a PhD programme in Experimental Medicine, he moved to UT Southwestern Medical Center where he completed his PhD programme. Dr. Schiattarella’s background is in medicine, experimental cardiology and cellular/molecular biology, with specific training and expertise in murine models of cardiovascular disease and preclinical assessment of cardiovascular function. His research interests include metabolic regulation of cardiac remodelling and failure (HFpEF and HFrEF), mitochondrial dysfunction, autophagy and epigenetics. Dr. Schiattarella has received numerous research awards including travel awards from the Council on Basic Cardiovascular Science of the European Society of Cardiology (2009–10), the Research Award for Young Investigator of the Italian Society of Cardiology (2011) and the STAR Award—Young Researcher Mobility of the University Federico II of Naples (2015). Funding Information: Dr. Joseph A. Hill is a cardiologist-scientist whose research focuses on molecular mechanisms of remodelling in the disease-stressed myocardium. He graduated with an MD, PhD from Duke University. Next, he pursued postdoctoral scientific training at the Institut Pasteur in Paris, followed by clinical training in Internal Medicine and Cardiology at the Brigham and Women’s Hospital, Harvard Medical School. Dr. Hill served on the faculty of the University of Iowa for 5 years before moving in 2002 to the University of Texas Southwestern Medical Center to assume the role of Chief of Cardiology and Director of the Harry S. Moss Heart Center. Dr. Hill’s research group strives to decipher mechanisms of structural, functional, metabolic, and electrical remodelling in heart disease with an eye toward therapeutic intervention. He has received numerous recognitions and awards, including election to the Association of American Professors; he recently served as President of the Association of University Cardiologists and chair of the Academic Council of the American College of Cardiology. Dr. Hill received the 2018 Research Achievement Award from the International Society for Heart Research. Presently, he serves as Editor-in-Chief of Circulation. Funding Information: This work was supported by grants from the National Institutes of Health (HL-120732; HL-126012; HL-128215), American Heart Association (14SFRN20510023; 14SFRN20670003), Fondation Leducq (11CVD04), and Cancer Prevention and Research Institute of Texas (RP110486P3).

PY - 2018/5/1

Y1 - 2018/5/1

UR - http://www.scopus.com/inward/record.url?scp=85047117336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047117336&partnerID=8YFLogxK

U2 - 10.1093/cvr/cvy048

DO - 10.1093/cvr/cvy048

M3 - Article

C2 - 29897494

AN - SCOPUS:85047117336

SN - 0008-6363

VL - 114

SP - e33-e35

JO - Cardiovascular Research

JF - Cardiovascular Research

IS - 6

ER -